Objective: This systematic review and meta-analysis aimed to evaluate whether
dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate …

Background The numbers of confirmed cases of coronavirus disease 2019 (COVID-19) and
COVID-19 related deaths are still increasing, so it is very important to determine the risk …

Background and aims The number of positive and death cases from coronavirus disease
2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is …

Objective The aim of this study was to analyze the available knowledge about the potential
association between dyslipidemia and the severity of coronavirus disease 2019 (COVID-19) …

Background Coronavirus disease 2019 (COVID-19) ranges from asymptomatic infection to
severe illness. Cholesterol in the host cell plasma membrane plays an important role in the …

Lipid profile alterations have been observed in patients with coronavirus disease 2019
(COVID-19) in relation to disease severity and mortality. We conducted a systematic review …

Summary Background Coronavirus disease-2019 (COVID-19) is a global pandemic. Studies
reported dyslipidemia in patients with COVID-19. Herein, we conducted a systematic review …

Background Non-clinical evidence and a few human studies with short follow-ups suggest
increased risk of dyslipidaemia in the post-acute phase of COVID-19 (ie,> 30 days after …

Background It has been reported that dyslipidemia is related to coronavirus-related
diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from …

The global coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2
coronavirus started in March 2020. The conclusions from numerous studies indicate that …